1200131-41-4 Usage
Description
1-(4-Bromo-2-chlorophenyl)methyl piperidine, also known as BCPM, is a chemical compound that belongs to the class of piperidine derivatives. It is a substituted piperidine compound with a bromo-chloro-phenyl ring attached to the piperidine ring. BCPM is known for its potential pharmacological activities, including its potential as an antipsychotic and analgesic agent. Its chemical structure and properties make it a promising candidate for the development of new drugs and treatment options. However, its safety and efficacy are still under investigation, and further research is needed to fully understand its potential therapeutic applications.
Uses
Used in Pharmaceutical Industry:
1-(4-Bromo-2-chlorophenyl)methyl piperidine is used as a research compound for its potential pharmacological activities. It is being investigated for its potential as an antipsychotic and analgesic agent due to its chemical structure and properties.
Used in Drug Development:
1-(4-Bromo-2-chlorophenyl)methyl piperidine is used as a promising candidate for the development of new drugs and treatment options. Its unique chemical structure and properties make it a valuable compound for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1200131-41-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,0,1,3 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1200131-41:
(9*1)+(8*2)+(7*0)+(6*0)+(5*1)+(4*3)+(3*1)+(2*4)+(1*1)=54
54 % 10 = 4
So 1200131-41-4 is a valid CAS Registry Number.
1200131-41-4Relevant articles and documents
DIAZACARBAZOLES AND METHODS OF USE
-
Page/Page column 158, (2010/01/07)
The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chkl) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
